Incyte Financial Statements (INCY)

Incytesmart-lab.ru %   2020 2021 2022 2023 2023   LTM ?
Report date 09.02.2021 08.02.2022 07.02.2023 31.12.2023 16.02.2024   29.10.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 2 667 2 986 3 395 3 696 3 696   4 076
Operating Income, bln rub -240.3 585.8 579.4 620.5 620.5   -52.0
EBITDA, bln rub ? -178.2 630.2 599.6 904.7 919.4   220.4
Net profit, bln rub ? -295.7 948.6 340.7 597.6 597.6   32.5
OCF, bln rub ? -124.6 749.5 969.9 496.5 496.5   101.8
CAPEX, bln rub ? 187.4 181.0 77.8 47.5 47.5   85.0
FCF, bln rub ? -312.0 568.5 892.1 449.0 449.0   16.8
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 2 776 2 235 2 596 2 791 1 190   3 780
Cost of production, bln rub 131.3 151.0 207.0 255.0 255.0   309.8
R&D, bln rub 2 216 1 458 1 586 1 628 1 628   2 585
Interest expenses, bln rub 2.17 1.91 2.67 2.55 2.55   2.67
Assets, bln rub 3 561 4 933 5 841 6 782 6 782   5 012
Net Assets, bln rub ? 2 611 3 770 4 370 5 190 5 190   3 171
Debt, bln rub 34.9 34.3 44.6 38.3 38.3   36.5
Cash, bln rub 1 801 2 348 3 239 3 656 3 656   1 775
Net debt, bln rub -1 767 -2 314 -3 194 -3 618 -3 618   -1 738
Ordinary share price, rub 87.0 73.4 80.3 62.8 62.8   54.0
Number of ordinary shares, mln 218.1 220.4 222.0 225.9 223.6   192.6
Market cap, bln rub 18 968 16 179 17 831 14 186 14 042   10 396
EV, bln rub ? 17 201 13 865 14 637 10 568 10 424   8 658
Book value, bln rub 2 283 3 464 4 085 4 911 4 911   2 896
EPS, rub ? -1.36 4.30 1.53 2.65 2.67   0.17
FCF/share, rub -1.43 2.58 4.02 1.99 2.01   0.09
BV/share, rub 10.5 15.7 18.4 21.7 22.0   15.0
EBITDA margin, % ? -6.68% 21.1% 17.7% 24.5% 24.9%   5.41%
Net margin, % ? -11.1% 31.8% 10.0% 16.2% 16.2%   0.80%
FCF yield, % ? -1.64% 3.51% 5.00% 3.17% 3.20%   0.16%
ROE, % ? -11.3% 25.2% 7.80% 11.5% 11.5%   1.02%
ROA, % ? -8.30% 19.2% 5.83% 8.81% 8.81%   0.65%
P/E ? -64.1 17.1 52.3 23.7 23.5   320.1
P/FCF -60.8 28.5 20.0 31.6 31.3   618.7
P/S ? 7.11 5.42 5.25 3.84 3.80   2.55
P/BV ? 8.31 4.67 4.36 2.89 2.86   3.59
EV/EBITDA ? -96.5 22.0 24.4 11.7 11.3   39.3
Debt/EBITDA 9.91 -3.67 -5.33 -4.00 -3.93   -7.89
R&D/CAPEX, % 1 183% 805.6% 2 038% 3 428% 3 428%   3 040%
CAPEX/Revenue, % 7.03% 6.06% 2.29% 1.28% 1.28%   2.09%
Incyte shareholders